97
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prior Opioid Exposure Influences Parents’ Sharing of Their Children’s CYP2D6 Research Results

, , , , , , , & show all
Pages 1199-1213 | Received 23 May 2017, Accepted 20 Jun 2017, Published online: 26 Jul 2017

References

  • Manolio TA . Implementing genomics and pharmacogenomics in the clinic: the National Human Genome Research Institute’s genomic medicine portfolio . Atherosclerosis253 , 225 – 236 ( 2016 ).
  • Kalia SS , AdelmanK , BaleSJet al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics . Genet. Med.19 ( 2 ), 249 – 255 ( 2017 ).
  • Lee EM , XuK , MosbrookEet al. Pharmacogenomic incidental findings in 308 families: the NIH Undiagnosed Diseases Program experience . Genet. Med.18 ( 12 ), 1303 – 1307 ( 2016 ).
  • Gordon AS , FultonRS , QinX , MardisER , NickersonDA , SchererS . PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation . Pharmacogenet. Genomics doi:10.1097/FPC.0000000000000202 ( 2016 ) ( Epub ahead of print ).
  • Relling MV , KleinTE . CPIC: Clinical Pharmacogenetics Implementation Consortium of the pharmacogenomics research network . Clin. Pharmacol. Ther.89 ( 3 ), 464 – 467 ( 2011 ).
  • Bollinger JM , ScottJ , DvoskinR , KaufmanD . Public preferences regarding the return of individual genetic research results: findings from a qualitative focus group study . Genet. Med.14 ( 4 ), 451 – 457 ( 2012 ).
  • Daack-Hirsch S , DriessnackM , HanishAet al. ‘Information is information’: a public perspective on incidental findings in clinical and research genome-based testing . Clin. Genet.84 ( 1 ), 11 – 18 ( 2013 ).
  • Haga SB , O’DanielJM , TindallGM , LipkusIR , AgansR . Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions . Genet. Med.13 ( 8 ), 723 – 728 ( 2011 ).
  • Murphy Bollinger J , BridgesJF , MohamedA , KaufmanD . Public preferences for the return of research results in genetic research: a conjoint analysis . Genet. Med.16 ( 12 ), 932 – 939 ( 2014 ).
  • Murphy J , ScottJ , KaufmanD , GellerG , LeroyL , HudsonK . Public expectations for return of results from large-cohort genetic research . Am. J. Bioeth.8 ( 11 ), 36 – 43 ( 2008 ).
  • Yu JH , CrouchJ , JamalSM , TaborHK , BamshadMJ . Attitudes of African Americans toward return of results from exome and whole genome sequencing . Am. J. Med. Genet. A161A ( 5 ), 1064 – 1072 ( 2013 ).
  • O’Daniel J , HagaSB . Public perspectives on returning genetics and genomics research results . Public Health Genomics14 ( 6 ), 346 – 355 ( 2011 ).
  • Bergner AL , BollingerJ , RaraighKSet al. Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings . Am. J. Med. Genet. A164A ( 11 ), 2745 – 2752 ( 2014 ).
  • Harris ED , ZinielSI , AmatrudaJGet al. The beliefs, motivations, and expectations of parents who have enrolled their children in a genetic biorepository . Genet. Med.14 ( 3 ), 330 – 337 ( 2012 ).
  • Ziniel SI , SavageSK , HuntingtonNet al. Parents’ preferences for return of results in pediatric genomic research . Public Health Genomics17 ( 2 ), 105 – 114 ( 2014 ).
  • Fernandez CV , SantorD , WeijerCet al. The return of research results to participants: pilot questionnaire of adolescents and parents of children with cancer . Pediatr. Blood Cancer48 ( 4 ), 441 – 446 ( 2007 ).
  • Sapp JC , DongD , StarkCet al. Parental attitudes, values, and beliefs toward the return of results from exome sequencing in children . Clin. Genet.85 ( 2 ), 120 – 126 ( 2014 ).
  • Wynn J , MartinezJ , DuongJet al. Research participants’ preferences for hypothetical secondary results from genomic research . J. Genet. Couns.26 ( 4 ), 841 – 851 ( 2017 ).
  • Facio FM , EidemH , FisherTet al. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study . Eur. J. Hum. Genet.21 ( 3 ), 261 – 265 ( 2013 ).
  • Graves KD , SinicropePS , EsplenMJet al. Communication of genetic test results to family and health-care providers following disclosure of research results . Genet. Med.16 ( 4 ), 294 – 301 ( 2014 ).
  • Crews KR , GaedigkA , DunnenbergerHMet al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype . Clin. Pharmacol. Ther.91 ( 2 ), 321 – 326 ( 2012 ).
  • Crews KR , GaedigkA , DunnenbergerHMet al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update . Clin. Pharmacol. Ther.95 ( 4 ), 376 – 382 ( 2014 ).
  • Jenco M . Breaking News. Do not use codeine, tramadol in children: FDA. AAP News , 20 April 2017 . www.aappublications.org/news/aapnewsmag/2017/04/20/Codeine042017.full.pdf .
  • Gammal RS , CrewsKR , HaidarCEet al. Pharmacogenetics for safe codeine use in sickle cell disease . Pediatrics138 ( 1 ), pii: e20153479 ( 2016 ).
  • George JA , ParkPS , HunsbergerJet al. An analysis of 34,218 pediatric outpatient controlled substance prescriptions . Anesth. Analg.122 ( 3 ), 807 – 813 ( 2016 ).
  • Groenewald CB , RabbittsJA , GebertJT , PalermoTM . Trends in opioid prescriptions among children and adolescents in the United States: a nationally representative study from 1996 to 2012 . Pain157 ( 5 ), 1021 – 1027 ( 2016 ).
  • Eckhardt K , LiS , AmmonS , SchanzleG , MikusG , EichelbaumM . Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation . Pain76 ( 1–2 ), 27 – 33 ( 1998 ).
  • Kirchheiner J , SchmidtH , TzvetkovMet al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication . Pharmacogenomics J.7 ( 4 ), 257 – 265 ( 2007 ).
  • Prows CA , ZhangX , HuthMMet al. Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study . Laryngoscope124 ( 5 ), 1242 – 1250 ( 2014 ).
  • Gaedigk A , SangkuhlK , Whirl-CarrilloM , KleinT , LeederJS . Prediction of CYP2D6 phenotype from genotype across world populations . Genet. Med.19 ( 1 ), 69 – 76 ( 2016 ).
  • Caudle KE , DunnenbergerHM , FreimuthRRet al. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) . Genet. Med.19 ( 2 ), 215 – 223 ( 2017 ).
  • Adelsperger S , ProwsCA , MyersMFet al. Parental perception of self-empowerment in pediatric pharmacogenetic testing: the reactions of parents to the communication of actual and hypothetical CYP2D6 test results . Health Commun.32 ( 9 ), 1104 – 1111 ( 2016 ).
  • Fukuda T , ChidambaranV , MizunoTet al. OCT1 genetic variants influence the pharmacokinetics of morphine in children . Pharmacogenomics14 ( 10 ), 1141 – 1151 ( 2013 ).
  • Sadhasivam S , ChidambaranV , OlbrechtVAet al. Opioid-related adverse effects in children undergoing surgery: unequal burden on younger girls with higher doses of opioids . Pain Med.16 ( 5 ), 985 – 997 ( 2015 ).
  • Sadhasivam S , ChidambaranV , ZhangXet al. Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics . Pharmacogenomics J.15 ( 2 ), 119 – 126 ( 2015 ).
  • Haga SB , O’DanielJM , TindallGM , LipkusIR , AgansR . Survey of US public attitudes toward pharmacogenetic testing . Pharmacogenomics J.12 ( 3 ), 197 – 204 ( 2012 ).
  • Burke W , EvansBJ , JarvikGP . Return of results: ethical and legal distinctions between research and clinical care . Am. J. Med. Genet. C166C ( 1 ), 105 – 111 ( 2014 ).
  • Jarvik GP , AmendolaLM , BergJSet al. Return of genomic results to research participants: the floor, the ceiling, and the choices in between . Am. J. Hum. Genet.94 ( 6 ), 818 – 826 ( 2014 ).
  • Haga SB , MillsR , MoaddebJ , Allen LapointeN , ChoA , GinsburgGS . Patient experiences with pharmacogenetic testing in a primary care setting . Pharmacogenomics17 ( 15 ), 1629 – 1636 ( 2016 ).
  • Bloss CS , SchorkNJ , TopolEJ . Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation . J. Med. Genet.51 ( 2 ), 83 – 89 ( 2014 ).
  • Madadi P , JolyY , AvardDet al. Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits . Clin. Pharmacol. Ther.88 ( 6 ), 792 – 795 ( 2010 ).
  • Olson JE , Rohrer VitekCR , BellEJet al. Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time) . Genet. Med.19 ( 7 ), 819 – 825 ( 2017 ).
  • Cadigan RJ , MichieM , HendersonG , DavisAM , BeskowLM . The meaning of genetic research results: reflections from individuals with and without a known genetic disorder . J. Empir. Res. Hum. Res. Ethics6 ( 4 ), 30 – 40 ( 2011 ).
  • O’Daniel J , LucasJ , DeverkaPet al. Factors influencing uptake of pharmacogenetic testing in a diverse patient population . Public Health Genomics13 ( 1 ), 48 – 54 ( 2010 ).
  • Haga SB , O’DanielJM , TindallGM , LipkusIR , AgansR . Survey of US public attitudes toward pharmacogenetic testing . Pharmacogenomics J.12 ( 3 ), 197 – 204 ( 2012 ).
  • Uddin SG , O’ConnorKS , AshmanJJ . Physician office visits by children for well and problem-focused care: United States, 2012 . NCHS Data Brief248 , 1 – 8 ( 2016 ).
  • Profile of Pediatric Visits . American Academy of Pediatrics , IL, USA ( 2010 ).
  • Moaddeb J , MillsR , HagaSB . Community pharmacists’ experience with pharmacogenetic testing . J. Am. Pharm. Assoc.55 ( 6 ), 587 – 594 ( 2015 ).
  • Crews KR , CrossSJ , MccormickJNet al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service . Am. J. Health Syst. Pharm.68 ( 2 ), 143 – 150 ( 2011 ).
  • Ferreri SP , GrecoAJ , MichaelsNMet al. Implementation of a pharmacogenomics service in a community pharmacy . J. Am. Pharm. Assoc.54 ( 2 ), 172 – 180 ( 2014 ).
  • O’Connor SK , FerreriSP , MichaelsNMet al. Making pharmacogenetic testing a reality in a community pharmacy . J. Am. Pharm. Assoc.52 ( 6 ), e259 – e265 ( 2012 ).
  • Gallo AM , AngstD , KnaflKA , HadleyE , SmithC . Parents sharing information with their children about genetic conditions . J. Pediatr. Heath Care19 ( 5 ), 267 – 275 ( 2005 ).
  • Metcalfe A , CoadJ , PlumridgeGM , GillP , FarndonP . Family communication between children and their parents about inherited genetic conditions: a meta-synthesis of the research . Eur. J. Hum. Genet.16 ( 10 ), 1193 – 1200 ( 2008 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.